- 期刊
Nonalcoholic Fatty Liver Disease and Associated Metabolic Risks of Hypertension in Type 2 Diabetes: A Cross-Sectional Community-Based Study
延伸閱讀
- 劉伊蟬（2020）。Testing the reliability and validity of the Adherence to Healthy Lifestyle Questionnaire and surveying the adherence of healthy lifestyle in patients with non-alcoholic fatty liver disease〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-1401202022374100
- Lai, C. L. (2005). Prevalence, Incidence, and Determinants of Non-alcoholic Fatty Liver Disease in Hyperendemic Hepatitis B/C Area: A Population-based Prospective Study [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2005.02144
- Kim, S. H., Lee, J. W., & Hwang, H. J. (2011). Associations between Combinations of Body Mass Index Plus Non-Alcoholic Fatty Liver Disease and Diabetes Mellitus among Korean Adults. Asia Pacific Journal of Clinical Nutrition, 20(1), 14-20. https://doi.org/10.6133/apjcn.2011.20.1.03
- Wang, C. H., Leung, C. H., Liu, S. C., & Chung, C. H. (2006). Safety and Effectiveness of Rosiglitazone in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease. Journal of the Formosan Medical Association, 105(9), 743-752. https://doi.org/10.29828/JFMA.200609.0007
- Lai, H. C., Lin, T., Lai, S. W., & Liao, K. F. (2008). Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Risk Factors in a Hospital-Based Study. 慈濟醫學雜誌, 20(3), 213-217. https://www.airitilibrary.com/Article/Detail?DocID=10163190-200809-20-3-213-217-a